InsiderClue
Insiders · Profile

Beetham Thomas W.

Chief Operating Officer at Viridian Therapeutics, Inc.\DE · See Remarks at Dianthus Therapeutics, Inc. /DE/ · EVP & Chief Legal Officer at Kiniksa Pharmaceuticals International. Filing since 14 Feb 2020. CIK 0001741382

VRDN Viridian Therapeutics, Inc.\DE Chief Operating Officer · 1 trade DNTH Dianthus Therapeutics, Inc. /DE/ See Remarks · 1 trade KNSA Kiniksa Pharmaceuticals International, plc EVP & Chief Legal Officer · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VRDN Viridian Therapeutics, Inc.\DE
27 Sep 2024
Chief Operating Officer
Bought
5,000
$117.05K
500%
DNTH Dianthus Therapeutics, Inc. /DE/
16 Sep 2021
See Remarks
Sold, plan not stated
6,103
$41.07K
30.5%
KNSA Kiniksa Pharmaceuticals International, plc
3 Feb 2021
EVP & Chief Legal Officer
Sold, plan not stated
2,477
$54.72K
0.8%
KNSA Kiniksa Pharmaceuticals International, plc
1 Jul 2020
EVP & Chief Legal Officer
Sold, plan not stated
29,589
$750.68K
100%
KNSA Kiniksa Pharmaceuticals International, plc
10 Jun 2020
EVP & Chief Legal Officer
Sold, plan not stated
13,752
$344.76K
31.7%
KNSA Kiniksa Pharmaceuticals International, plc
21 Apr 2020
EVP & Chief Legal Officer
Sold, plan not stated
2,518
$50.09K
7.8%
KNSA Kiniksa Pharmaceuticals International, plc
20 Apr 2020
EVP & Chief Legal Officer
Sold, plan not stated
47,423
$903.88K
59.6%
KNSA Kiniksa Pharmaceuticals International, plc
14 Feb 2020
EVP & Chief Legal Officer
Sold, plan not stated
59
$1.10K
0.1%
8 decisions on file.